"I think it will, because it's too confused right now. The whole sector is being sort of under the purview of multi- ministerial control. So, I think that is causing a lot of chaos", the chief of Biocon, the country's biggest biotech company told PTI.
Union Fertilisers Minister H N Ananth Kumar in December had said that there would be a separate ministry for pharma and medical devices sector in the next one year.
Mazumdar-Shaw, also Chairperson of the Board of Governors at IIM, Bangalore made out a strong case for adequately staffing the drug control administration.
"Our regulatory standards are pretty high. It's just that they don't have enough people to invigilate. Today, the Drugs Controller is very poorly staffed, and he needs more people, he has been asking for more people. If you don't have more people, how will you carry out all the audits?
"And then it's also a state subject, not Centre either. So, there are some states where quality standards are high, some states where it is low. So, it's a bit of mixed bag", she said.
On perception issue of Indian generic industry not being quality compliant, Mazumdar-Shaw said: "Please understand, quality is a big issue, compliant is a big issue, and India has to build credibility in that front. The only way to deal with perception is to build credibility".
Mazumdar-Shaw further said India's pharmacy colleges need to revamp curricula and also invest in infrastructure and leverage the power of internet to offer best of education standards.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)